![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SMARCD2 |
Gene summary for SMARCD2 |
![]() |
Gene information | Species | Human | Gene symbol | SMARCD2 | Gene ID | 6603 |
Gene name | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 | |
Gene Alias | BAF60B | |
Cytomap | 17q23.3 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q92925 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6603 | SMARCD2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.44e-04 | 2.55e-01 | 0.0155 |
6603 | SMARCD2 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.14e-09 | 4.69e-01 | -0.1808 |
6603 | SMARCD2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.05e-10 | 5.48e-01 | -0.0811 |
6603 | SMARCD2 | HTA11_78_2000001011 | Human | Colorectum | AD | 4.34e-05 | 4.07e-01 | -0.1088 |
6603 | SMARCD2 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.76e-11 | 4.38e-01 | -0.1954 |
6603 | SMARCD2 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.85e-03 | 7.01e-01 | -0.2602 |
6603 | SMARCD2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.99e-03 | 3.66e-01 | -0.1207 |
6603 | SMARCD2 | HTA11_83_2000001011 | Human | Colorectum | SER | 3.19e-05 | 4.37e-01 | -0.1526 |
6603 | SMARCD2 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.37e-22 | 6.44e-01 | -0.1464 |
6603 | SMARCD2 | HTA11_866_2000001011 | Human | Colorectum | AD | 5.60e-07 | 3.33e-01 | -0.1001 |
6603 | SMARCD2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.80e-20 | 7.92e-01 | -0.059 |
6603 | SMARCD2 | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.05e-03 | 4.58e-01 | -0.2061 |
6603 | SMARCD2 | HTA11_546_2000001011 | Human | Colorectum | AD | 2.47e-03 | 4.04e-01 | -0.0842 |
6603 | SMARCD2 | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.79e-04 | 4.73e-01 | -0.0179 |
6603 | SMARCD2 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.61e-19 | 6.86e-01 | 0.096 |
6603 | SMARCD2 | HTA11_4255_2000001011 | Human | Colorectum | SER | 2.71e-03 | 4.81e-01 | 0.0446 |
6603 | SMARCD2 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.41e-06 | 6.49e-01 | 0.0528 |
6603 | SMARCD2 | HTA11_7663_2000001011 | Human | Colorectum | SER | 1.32e-02 | 5.79e-01 | 0.0131 |
6603 | SMARCD2 | HTA11_10623_2000001011 | Human | Colorectum | AD | 1.19e-04 | 5.52e-01 | -0.0177 |
6603 | SMARCD2 | HTA11_6801_2000001011 | Human | Colorectum | SER | 2.56e-06 | 7.78e-01 | 0.0171 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000632517 | Esophagus | ESCC | chromatin organization | 240/8552 | 409/18723 | 6.52e-08 | 1.14e-06 | 240 |
GO:003149811 | Esophagus | ESCC | chromatin disassembly | 16/8552 | 20/18723 | 1.85e-03 | 8.40e-03 | 16 |
GO:003298616 | Esophagus | ESCC | protein-DNA complex disassembly | 16/8552 | 20/18723 | 1.85e-03 | 8.40e-03 | 16 |
GO:000633713 | Esophagus | ESCC | nucleosome disassembly | 14/8552 | 18/18723 | 5.77e-03 | 2.14e-02 | 14 |
GO:002241112 | Liver | HCC | cellular component disassembly | 282/7958 | 443/18723 | 1.02e-19 | 1.38e-17 | 282 |
GO:003298411 | Liver | HCC | protein-containing complex disassembly | 138/7958 | 224/18723 | 5.59e-09 | 1.46e-07 | 138 |
GO:000632511 | Liver | HCC | chromatin organization | 206/7958 | 409/18723 | 7.23e-04 | 4.41e-03 | 206 |
GO:003298611 | Liver | HCC | protein-DNA complex disassembly | 15/7958 | 20/18723 | 3.31e-03 | 1.51e-02 | 15 |
GO:000633711 | Liver | HCC | nucleosome disassembly | 13/7958 | 18/18723 | 1.05e-02 | 3.89e-02 | 13 |
GO:00314983 | Liver | HCC | chromatin disassembly | 14/7958 | 20/18723 | 1.21e-02 | 4.41e-02 | 14 |
GO:002241119 | Oral cavity | OSCC | cellular component disassembly | 283/7305 | 443/18723 | 9.57e-27 | 3.37e-24 | 283 |
GO:003298410 | Oral cavity | OSCC | protein-containing complex disassembly | 136/7305 | 224/18723 | 3.42e-11 | 1.13e-09 | 136 |
GO:000632510 | Oral cavity | OSCC | chromatin organization | 190/7305 | 409/18723 | 1.17e-03 | 5.97e-03 | 190 |
GO:00329868 | Oral cavity | OSCC | protein-DNA complex disassembly | 15/7305 | 20/18723 | 1.19e-03 | 5.99e-03 | 15 |
GO:00063375 | Oral cavity | OSCC | nucleosome disassembly | 13/7305 | 18/18723 | 4.45e-03 | 1.79e-02 | 13 |
GO:002241117 | Prostate | BPH | cellular component disassembly | 121/3107 | 443/18723 | 6.34e-09 | 2.25e-07 | 121 |
GO:00329849 | Prostate | BPH | protein-containing complex disassembly | 65/3107 | 224/18723 | 2.19e-06 | 3.60e-05 | 65 |
GO:00063259 | Prostate | BPH | chromatin organization | 101/3107 | 409/18723 | 1.52e-05 | 1.94e-04 | 101 |
GO:00329867 | Prostate | BPH | protein-DNA complex disassembly | 10/3107 | 20/18723 | 5.73e-04 | 3.98e-03 | 10 |
GO:00063382 | Prostate | BPH | chromatin remodeling | 62/3107 | 255/18723 | 9.47e-04 | 5.97e-03 | 62 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04714 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa05225 | Colorectum | AD | Hepatocellular carcinoma | 59/2092 | 168/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 59 |
hsa047141 | Colorectum | AD | Thermogenesis | 120/2092 | 232/8465 | 2.76e-19 | 1.16e-17 | 7.37e-18 | 120 |
hsa052251 | Colorectum | AD | Hepatocellular carcinoma | 59/2092 | 168/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 59 |
hsa047142 | Colorectum | SER | Thermogenesis | 106/1580 | 232/8465 | 1.15e-21 | 6.34e-20 | 4.61e-20 | 106 |
hsa047143 | Colorectum | SER | Thermogenesis | 106/1580 | 232/8465 | 1.15e-21 | 6.34e-20 | 4.61e-20 | 106 |
hsa047144 | Colorectum | MSS | Thermogenesis | 113/1875 | 232/8465 | 1.52e-19 | 4.62e-18 | 2.83e-18 | 113 |
hsa052252 | Colorectum | MSS | Hepatocellular carcinoma | 56/1875 | 168/8465 | 5.04e-04 | 3.45e-03 | 2.11e-03 | 56 |
hsa047145 | Colorectum | MSS | Thermogenesis | 113/1875 | 232/8465 | 1.52e-19 | 4.62e-18 | 2.83e-18 | 113 |
hsa052253 | Colorectum | MSS | Hepatocellular carcinoma | 56/1875 | 168/8465 | 5.04e-04 | 3.45e-03 | 2.11e-03 | 56 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0522518 | Esophagus | ESCC | Hepatocellular carcinoma | 109/4205 | 168/8465 | 4.27e-05 | 1.88e-04 | 9.64e-05 | 109 |
hsa04714310 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0522519 | Esophagus | ESCC | Hepatocellular carcinoma | 109/4205 | 168/8465 | 4.27e-05 | 1.88e-04 | 9.64e-05 | 109 |
hsa0471422 | Liver | HCC | Thermogenesis | 170/4020 | 232/8465 | 5.36e-16 | 2.25e-14 | 1.25e-14 | 170 |
hsa052258 | Liver | HCC | Hepatocellular carcinoma | 106/4020 | 168/8465 | 2.87e-05 | 1.85e-04 | 1.03e-04 | 106 |
hsa0471432 | Liver | HCC | Thermogenesis | 170/4020 | 232/8465 | 5.36e-16 | 2.25e-14 | 1.25e-14 | 170 |
hsa0522511 | Liver | HCC | Hepatocellular carcinoma | 106/4020 | 168/8465 | 2.87e-05 | 1.85e-04 | 1.03e-04 | 106 |
hsa0471430 | Oral cavity | OSCC | Thermogenesis | 138/3704 | 232/8465 | 7.67e-07 | 4.35e-06 | 2.22e-06 | 138 |
hsa0522516 | Oral cavity | OSCC | Hepatocellular carcinoma | 97/3704 | 168/8465 | 1.63e-04 | 5.52e-04 | 2.81e-04 | 97 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SMARCD2 | SNV | Missense_Mutation | c.1268T>A | p.Phe423Tyr | p.F423Y | Q92925 | protein_coding | tolerated(0.05) | probably_damaging(0.991) | TCGA-A8-A09Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD | |
SMARCD2 | insertion | Frame_Shift_Ins | novel | c.1320_1321insTTCCTAGCCTTTCTAAACCAAAGTTCTTTGCCATTCCTACAAGCCCA | p.His441PhefsTer26 | p.H441Ffs*26 | Q92925 | protein_coding | TCGA-B6-A0IN-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
SMARCD2 | SNV | Missense_Mutation | c.417G>C | p.Lys139Asn | p.K139N | Q92925 | protein_coding | deleterious(0) | possibly_damaging(0.764) | TCGA-IR-A3LH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
SMARCD2 | SNV | Missense_Mutation | rs757140754 | c.1417C>T | p.Arg473Cys | p.R473C | Q92925 | protein_coding | tolerated(0.06) | benign(0.003) | TCGA-A6-6780-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SMARCD2 | SNV | Missense_Mutation | c.1009N>T | p.Leu337Phe | p.L337F | Q92925 | protein_coding | deleterious(0.03) | probably_damaging(0.926) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
SMARCD2 | SNV | Missense_Mutation | rs750388563 | c.1300N>A | p.Ala434Thr | p.A434T | Q92925 | protein_coding | tolerated(0.22) | benign(0.022) | TCGA-AY-4071-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SMARCD2 | SNV | Missense_Mutation | rs866391405 | c.1100N>A | p.Arg367Gln | p.R367Q | Q92925 | protein_coding | tolerated(0.06) | probably_damaging(0.995) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SMARCD2 | SNV | Missense_Mutation | rs749078019 | c.314N>A | p.Pro105His | p.P105H | Q92925 | protein_coding | deleterious(0) | possibly_damaging(0.838) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
SMARCD2 | SNV | Missense_Mutation | c.1507G>A | p.Ala503Thr | p.A503T | Q92925 | protein_coding | tolerated(0.58) | benign(0.114) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
SMARCD2 | SNV | Missense_Mutation | rs759533186 | c.1186N>A | p.Asp396Asn | p.D396N | Q92925 | protein_coding | deleterious(0.04) | probably_damaging(0.964) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |